Program
Sodium Fluoride
Also written as “NaF”, “cetylpyridinium chloride (CPC), zinc lactate and sodium fluoride Mouthwash” and “0.022% Sodium Fluoride mouthwash”.
Its studies are mostly in Gingivitis · Tooth Erosion · Tooth Discoloration · Dental Plaque · Dentin Sensitivity, led by 4 companies.
Drug pageSodium Fluoride: every studyAll 54 studies of it, academic ones too, with its approvals, label and forms.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| GlaxoSmithKlineits history only | 110 open or running | phase 3since Jul 1, 2008 | Jul 1, 2008 | none ahead |
| Colgate Palmolive | 30 open or running | phase 3since Jun 27, 2024 | Jun 27, 2024 | none ahead |
| Procter and Gambleits history only | 10 open or running | phase 2since Mar 19, 2025 | Mar 19, 2025 | none ahead |
| Protegeraits history only | 10 open or running | early phase 1since Oct 4, 2023 | Oct 4, 2023 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Colgate Palmolive only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jun 27, 2024First study: phase 3 study in Tooth DiscolorationFirst studyNCT06486974 · 80 enrolled · Dominican Republic
- Nov 24, 2025Phase 3 study in GingivitisNCT07263698 · 80 enrolled · Italy
- Jan 27, 2026Phase 3 study in Plaque, AmyloidNCT07398846 · 134 enrolled · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 Colgate Palmolive leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07398846Plaque, Amyloid · United States | 3 | Completed | Apr 29, 2026 | 134 |
| NCT07263698Gingivitis · Italy | 3 | Completed | Feb 27, 2026 | 80 |
| NCT06486974Tooth Discoloration · Dominican Republic | 3 | Completed | Nov 8, 2024 | 80 |
How it is read
Names in the registry
- “NaF”, 2 entries
- “cetylpyridinium chloride (CPC), zinc lactate and sodium fluoride Mouthwash”, 1 entry
- “0.022% Sodium Fluoride mouthwash”, 1 entry
- “Sodium Fluoride Dentifrice”, 1 entry
- “Protegera™ toothpaste (NaF)”, 1 entry
Conditions, from the studies’ own filings
- Gingivitis, 3 studies
- Tooth Erosion, 2 studies
- Tooth Discoloration, 1 study
- Dental Plaque, 1 study
- Dentin Sensitivity, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.